515 filings
Page 2 of 26
424B3
8rsumnik7the4v
14 Aug 20
Prospectus supplement
5:22pm
424B3
rzo7b2nz5jcm uhkx
31 Jul 20
Prospectus supplement
12:00am
EFFECT
ky4xu4d us
29 Jul 20
Notice of effectiveness
12:15am
CORRESP
xouc7lwfn617xsy
24 Jul 20
Correspondence with SEC
12:00am
D/A
u9yn2nul p7xzc
23 Jul 20
Indefinite amount in debt / Debt convertible into equity., sold $5.61M, 18 investors
5:00pm
UPLOAD
cmy4w1wx
22 Jul 20
Letter from SEC
12:00am
8-K
u1pnq
9 Jul 20
Entry into a Material Definitive Agreement
4:16pm
8-K
k3q06e 092vhv5
23 Jun 20
Entry into a Material Definitive Agreement
5:00pm
8-K
zsnos 3yg6bbrax
19 Jun 20
Entry into a Material Definitive Agreement
4:15pm
D
tl5sykrrg2nmrdt i3z1
12 Jun 20
Indefinite amount in debt / Debt convertible into equity, sold $2.42M, 9 investors
4:46pm
SC 13G
ar57ytyusq
10 Jun 20
GT Biopharma / BRISTOL INVESTMENT FUND ownership change
8:08am
4
wt6djvkw
4 Jun 20
GT Biopharma / Tony Cataldo ownership change
5:15pm
8-K
jfr iishp0ep
29 May 20
Regulation FD Disclosure
4:15pm
SC 13G/A
07xdluxdxg59yt wl0o
18 May 20
GT Biopharma / BRISTOL INVESTMENT FUND ownership change
4:06pm
4
e3baw1yj1 urxq1bs
14 May 20
GT Biopharma / Steven W Weldon ownership change
1:40pm